(Updates to say recall has been completed; earlier story was corrected to clarify Gilead’s recall of two lots of Remdesivir was originally reported on Dec. 3.)
Gilead’s recall of two lots of Remdesivir has been completed and FDA has terminated this recall, the agency said on its website.
To contact the reporter on this story:
To contact the editor responsible for this story:
© 2022 Bloomberg L.P. All rights reserved. Used with permission.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
